← Back to Search

Dietary Factors in Prostate Cancer Screening

Phase 2

Waitlist Available

Led By Kenneth T. Bogen, DrPH, MPH, MA, ScD

Research Sponsored by Lawrence Livermore National Laboratory at University of California

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

No medical or other disability (e.g., blindness, psychological dysfunction, or amputation) that would preclude study participation

African American male

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Study Summary

This trial is screening African American men for prostate cancer and studying how dietary heterocyclic amines affects screening results and prostate cancer risk.

Who is the study for?

This trial is for African American men who want routine prostate cancer screening, live near Oakland, California, speak English, and have no disabilities that would prevent participation. They must not have had a previous diagnosis of prostate cancer.Check my eligibility

What is being tested?

The study is looking at how prostate cancer screenings might work better when considering the amount of heterocyclic amines in the diet. Heterocyclic amines are chemicals formed in some foods during cooking at high temperatures.See study design

What are the potential side effects?

Since this trial focuses on screening methods and dietary analysis rather than medication or invasive procedures, it does not list specific side effects related to interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I do not have any health issues that would stop me from joining the study.

Select...

I am an African American male.

Select...

I have never been diagnosed with prostate cancer.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Correlation of HA exposure with prostate cancer screening results

Dietary heterocyclic amine (HA) exposure in African American men

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,660 Previous Clinical Trials

40,923,721 Total Patients Enrolled

560 Trials studying Prostate Cancer

506,295 Patients Enrolled for Prostate Cancer

Lawrence Livermore National Laboratory at University of CaliforniaLead Sponsor

Kenneth T. Bogen, DrPH, MPH, MA, ScDPrincipal InvestigatorLawrence Livermore National Laboratory at University of California

Media Library

Prostate Cancer Screening Clinical Trial Eligibility Overview. Trial Name: NCT00354497 — Phase 2

Prostate Cancer Clinical Trial 2023: Prostate Cancer Screening Highlights & Side Effects. Trial Name: NCT00354497 — Phase 2

Prostate Cancer Screening 2023 Treatment Timeline for Medical Study. Trial Name: NCT00354497 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research project recruiting new participants?

"According to clinicaltrials.gov, this particular research endeavour is no longer accepting patients; the initial post was issued on March 1st 2002 and it has been modified as recently as September 19th 2013. Nevertheless, a variety of other medical trials are currently recruiting participants - 1321 in total."

Answered by AI

What are the criteria for enrollment in this research project?

"This trial is seeking to enrol 800 individuals, aged between 50 and 70 years old, who have recently been diagnosed with prostate cancer. To be eligible for the study participants must not previously have had any diagnosis of this disease, possess no medical or physical disability that would stop them from participating in the experiment; hold a residence within close proximity Oakland, California."

Answered by AI